On 2023-11-09, NeuBase Therapeutics, Inc. (NBSE) announced earnings per share of $-0.95 for the fiscal quarter ending 2023-09-30, beating the average analyst estimate of $-1.82.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2023-11-09 | 2023-09-30 | $-1.82 | $-0.95 |
| 2023-08-14 | 2023-06-30 | $-1.80 | $-1.26 |
| 2023-05-11 | 2023-03-31 | $-2.00 | $-2.40 |
| 2023-02-14 | 2022-12-31 | $-2.20 | $-2.60 |
| 2022-12-21 | 2022-09-30 | $-5.40 | $-4.80 |
| 2022-08-11 | 2022-06-30 | $-6.00 | $-5.20 |
| 2022-05-12 | 2022-03-31 | $-5.20 | $-6.00 |
| 2022-02-10 | 2021-12-31 | $-5.00 | $-4.80 |
| 2021-12-23 | 2021-09-30 | $-5.40 | $-4.20 |
| 2021-08-12 | 2021-06-30 | $-4.80 | $-5.80 |
| 2021-05-13 | 2021-03-31 | $-4.60 | $-4.80 |
| 2021-02-11 | 2020-12-31 | $-4.80 | $-3.60 |
| 2020-12-23 | 2020-09-30 | $-4.00 | $-4.00 |
| 2020-08-13 | 2020-06-30 | $-4.80 | $-3.60 |
| 2020-05-14 | 2020-03-31 | $-4.40 | $-5.20 |
| 2020-03-26 | 2019-12-31 | $-7.20 | $-5.20 |
| 2019-08-14 | 2019-06-30 | -- | $-8.00 |
| 2019-05-15 | 2019-03-31 | -- | $-8.00 |
| 2019-02-14 | 2018-12-31 | -- | $-6.40 |
| 2018-08-14 | 2018-06-30 | -- | $-4.00 |
| 2018-05-15 | 2018-03-31 | -- | $-20.00 |
| 2018-02-14 | 2017-12-31 | -- | $-28.00 |
| 2017-12-15 | 2017-09-30 | $-32.00 | $-32.00 |
| 2017-08-08 | 2017-06-30 | $-100.00 | $-28.00 |
| 2017-05-11 | 2017-03-31 | $-120.00 | $-84.00 |
| 2017-02-14 | 2016-12-31 | $-76.00 | $-84.00 |
| 2016-12-22 | 2016-09-30 | $-96.00 | $-84.00 |
| 2016-08-09 | 2016-06-30 | $-92.00 | $-96.00 |
| 2016-05-10 | 2016-03-31 | -- | $-68.00 |
| 2016-02-09 | 2015-12-31 | $-96.00 | $-80.00 |
| 2015-12-10 | 2015-09-30 | $-96.00 | $-52.00 |
| 2015-08-06 | 2015-06-30 | $-84.00 | $-44.00 |
| 2015-05-11 | 2015-03-31 | $-68.00 | $-48.00 |
| 2015-02-09 | 2014-12-31 | -- | $-72.00 |